Puma Biotechnology Inc. buy blaugold
Start price
08.10.19
/
50%
€7.96
Target price
14.10.19
€10.00
Performance (%)
-20.97%
End price
14.10.19
€6.29
Summary
This prediction ended on 14.10.19 with a price of €6.29. The prediction for Puma Biotechnology Inc. disappointed with a performance of -20.97%. blaugold has 50% into this predictionPuma Biotechnology is a publicly traded biopharmaceutical company that develops innovative cancer therapies targeting the most aggressive and difficult-to-treat forms of the disease. Puma's lead product is Nerlynx, an oral medication approved for the treatment of HER2-positive breast cancer, and the company also has a number of other promising drugs in its pipeline. Founded in 2010, Puma is headquartered in Los Angeles, California, and its shares trade on the NASDAQ exchange under the ticker symbol PBYI.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Puma Biotechnology Inc. | -6.878% | -6.878% | 86.059% | -45.308% |
| iShares Core DAX® | 0.160% | -1.640% | 12.016% | 15.557% |
| iShares Nasdaq 100 | -3.020% | -4.715% | 37.102% | 42.685% |
| iShares Nikkei 225® | -2.519% | -7.621% | 18.066% | 2.904% |
| iShares S&P 500 | -1.377% | -2.809% | 26.536% | 41.689% |
Comments by blaugold for this prediction
In the thread Puma Biotechnology Inc. diskutieren
Buy mit Kursziel 10,0
Stopped prediction by blaugold for Puma Biotechnology Inc.
Puma Biotechnology Inc.
Start price
Target price
Perf. (%)
€3.95
19.03.24
19.03.24
-
19.03.25
19.03.25
27.59%
30.03.24
30.03.24
Puma Biotechnology Inc.
Start price
Target price
Perf. (%)
€2.87
21.11.21
21.11.21
-
21.11.22
21.11.22
-0.24%
27.11.21
27.11.21
Puma Biotechnology Inc.
Start price
Target price
Perf. (%)
€8.82
07.08.20
07.08.20
€10.00
10.08.20
10.08.20
-0.32%
10.08.20
10.08.20